Lupus Anticoagulant: Performance of a New, Fully Automated Commercial Screening and Confirmation Assay
Barbara Montaruli(A. O. Ordine Mauriziano di Torino), Mario Bazzan(Ospedale San Giovanni Bosco), A Vaccarino(Istituto di Ematologia di Bologna), Cecilia Agnes, M Saitta, Cecilia Rus, Cristina Foli(JNC (Japan))
Cited by 2
Related Papers
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
|New England Journal of Medicine|2001|599
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
|Journal of Clinical Oncology|2005|305
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
|Internal and Emergency Medicine|2008|126
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism
|European Respiratory Journal|2017|123
Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT)
|Thrombosis and Haemostasis|2008|121